Testing a new medicine in healthy adults
This study tests a new medicine, ART105, in healthy adults to see if it is safe and how the body handles it. It is an early-stage trial, so it may not directly help you, but you would be contributing to medical research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You are in good general health, with no major medical issues.
- You weigh at least 50 kg (110 lbs) if male, or 45 kg (99 lbs) if female, and your BMI is between 19 and 26.
- You agree to use effective birth control during the study if you or your partner can have children.
- You have not taken any prescription or over-the-counter medicines, or herbal supplements, in the last 14 days.
- You are not currently in another clinical trial and haven't been in one in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.
This trial tests a new drug called CAY001 in healthy volunteers to see how safe it is and how the body processes it. It may help researchers understand if the drug is safe enough to test in people with medical conditions later.
This early-phase study tests a new experimental drug (M5542) in healthy volunteers to see how safe it is and how the body processes a single dose. If you are in good health and meet simple weight and medical history criteria, you may be able to join.
This early-stage study tests how a new experimental medicine moves through and leaves the body in healthy volunteers. Researchers will compare different forms of the medicine to understand which works best and is safest.
This study tests a new medicine (BI 3776528) in healthy men to see how well different doses are tolerated. It helps researchers find the safest dose before testing in people with a condition.
This is an early-stage study testing a new investigational drug called IG001119 in people who are in good health. Researchers will give increasing doses to small groups to learn how the drug is processed by the body and to check for any side effects.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.